Merck (MRK)

Price/Share*:	$38.42	Annualized Dividend:	$1.68	Div. Yield:	4.37%
52-Week High:	$39.43	% Off 52-Week High:	-2.56%	52-Week Low:	$29.47

Recent/Upcoming Dividend Payouts for MRK

Amount	Ex-Dividend Date	Record Date	Pay Date	Declare Date	Qualified? [?]	Type
MRK has not yet officially announced its next dividend payout.
$0.42	12/13/2011	12/15/2011	1/9/2012	11/10/2011	Yes	Regular
$0.38	9/13/2011	9/15/2011	10/7/2011	7/26/2011	Yes	Regular
$0.38	6/13/2011	6/15/2011	7/8/2011	5/24/2011	Yes	Regular
$0.38	3/11/2011	3/15/2011	4/7/2011	2/22/2011	Yes	Regular

MRK's Dividend Payout Frequency: Quarterly

View Historical Dividend Data for MRK »

Add MRK to My Watchlist »

DARS™ Stock Ratings for MRK

If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Merck (MRK) in this space, including whether we think your should Buy, Hold, or Sell this stock.

Sign up for Dividend.com Premium today to gain access to ratings on nearly 1,600 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!

Subscribe to Dividend.com Premium Today! »

Recent Dividend.com Articles for MRK

Feb 4, 2012This Past Week's Earnings/Story Stocks Winners & Losers - Feb.4 Edition
Feb 4, 2012This Week's Best & Worst Performing Analyst Downgrades - Feb.4 Edition
Feb 4, 2012Best Large Cap Dividend Stock Prospects List - Feb.4 Edition
Feb 2, 2012Merck Q4 Profit Beats Expectations, but Revenue Falls Short (MRK)
Feb 1, 2012Best Large Cap Dividend Stock Prospects List - Year-To-Date Performance
Jan 28, 2012This Week's Best & Worst Performing Analyst Upgrades - Jan.28 Edition
Jan 28, 2012Best Large Cap Dividend Stock Prospects List - Jan.28 Edition
Jan 21, 2012Best Large Cap Dividend Stock Prospects List - Jan.21 Edition
Jan 14, 2012This Week's Best & Worst Performing Analyst Downgrades - Jan.14 Edition
Jan 14, 2012Best Large Cap Dividend Stock Prospects List - Jan.14 Edition

Page 1 of 23

1 2 3

...

21 22 23 Next »

Merck (MRK) Company Profile

Merck & Co., Inc. (MRK) is a global pharmaceuticals provider. The company operates in four units: Pharmaceutical, Animal Health, Consumer Care and Alliances. Its popular drug treatments include Singulair (asthma), Cozaar/Hyzaar and Vasotec (hypertension/heart failure), Fosamax (osteoporosis), and Zocor (cholesterol), among many others. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information on this website represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.